期刊文献+

大肠埃希菌Ⅰ类整合子与多药耐药的相关性探讨 被引量:22

Relationship between Type Ⅰ integron and multidrug resistance in escherichia coli
原文传递
导出
摘要 目的探讨临床分离多药耐药大肠埃希菌(ECO)的Ⅰ类整合子流行分布及与多药耐药之间可能存在的关系。方法采用纸片扩散法(K-B法)检测71株大肠埃希菌对3类4种常用抗菌药物的药敏率;PCR方法检测Ⅰ类整合子3个不同部位的基因。结果 71株大肠埃希菌耐庆大霉素47株为66.20%、耐左氧氟沙星45株为63.38%、耐头孢噻肟42株为59.15%、耐头孢他啶13株为18.31%,多药耐药率为32.39%;Ⅰ类整合子的总检出率为88.73%,整合子阳性与阴性株对庆大霉素、左氧氟沙星、头孢噻肟的药敏分布差异有统计学意义(P<0.05),多药耐药菌株中Ⅰ类整合子基因的阳性率为100.0%,耐多药菌株与全敏感菌株差异有统计学意义(P<0.05)。结论大肠埃希菌的Ⅰ类整合子的检出率高,且与其多药耐药性密切相关。 OBJECTIVE To investigate the distribution of type I integron in local multidrug resistant Escherichia coli(E, coli), to analyze the possible relationship between the type I integron and multidrug resistance. METHODS The susceptibilities of 71 E. coli strains to 4 antibiotics were detected by disk diffusion test. IntI1 gene, variable region,qacEDeltal-sull gene, which were in 3 different parts in type I integron, were detected bY PCR. RESULTS Totally 47 strains(66.20%) were resistant to gentamicin, 45 strains (63.38%) to levofloxacin, 42 strains(59. 15%)to cefotaxime, and 13 strains(18. 31%)to ceftazidime. There were 23 (32. 39%)multidrug resistant strains in 71 E. coli strains. The positive rate of type I integron 71 E. coli strains was 88.73%. The constituent ratio of susceptibility to gentamicin, levofloxacin and cefotaxime in integron-positive strains was statistically different from that in integron-negative strains. The type I integron-positive rates were 100. 00% in multidrug resistant, which were statistically different with that in sensitive strains (P〈0.05). CONCLUSION The high detection rate of type I integron in E. coli is high, which is cosely associated with the multidrug resistance.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2011年第14期2882-2885,共4页 Chinese Journal of Nosocomiology
基金 四川省重点学科重点建设项目资助(SZD0241)
关键词 大肠埃希菌 多药耐药 I类整合子 Escherichia coli Multidrug resistance, Type I integron
  • 相关文献

参考文献13

  • 1Saeed MA, Haque A, Ali A, et al. Relationship of drug resistance to phylogenetic groups of E. coli isolates from wound infections[J]. Infect Dev Ctries,2009,3(9) :667-670.
  • 2顾兵,童明庆,刘根焰,倪芳,赵旺胜,梅亚宁,文怡,魏源华,黄珮珺,潘世扬.整合子介导大肠埃希菌和克雷伯菌多重耐药机制的研究[J].中华检验医学杂志,2006,29(8):725-729. 被引量:28
  • 3李智山,周乐翔,赵建忠,杨燕,邓三季,邹玖明.大肠埃希菌Ⅰ类整合子遗传标记研究[J].世界感染杂志,2008,8(2):113-114. 被引量:5
  • 4Ahmed MO, Clegg PD, Williams NJ, et al. Antimierobial resistance in equine faecal Escherichia coli isolates from North West England[J]. Ann Clin Antimierob, 2010,9 : 12.
  • 5Zhang XY, Ding LJ, Yue J. Occurrence and characteristics of class 1 and class 2 integrons in resistant Escherichla coli iso- lates frrm animals and farm workers in northeastern china[J]. Microb Drug Resist,2009,15(4) :323-328.
  • 6Yang CM, Lin MF, Lin CH, et al. Characterization of anti- microbial resistance patterns and integrons in human fecalEscherichia coli in Taiwan[J]. JpnJ Infect Dis, 2009,62 (3) : 177-181.
  • 7Ajiboye RM, Solberg OD, Lee BM, et al. Global spread of mobile antimicrobial drug resistance determinants in humanand animal Escherlchia coli and Salmonella strains causing community-acquired infections[J]. Clin Infect Dis, 2009, 49 (3) :365-371.
  • 8Vasilakopoulou A, Psiehogiou M, Tzouvelekis L, etal. Prevalence and characterization of class 1 integrons in Escherichiacoli of poulty and human origin[J]. Foodborne Pathog Dis, 2009,6(10) : 1211-1218.
  • 9Xu H, Su Z, Wang S, et al. Four novel resistance integron gene cassette occurrences in bacterial isolates from Zhenjiang china[J]. Curr Microbiol,2009,59(2) : 113-117.
  • 10Nawaz M, Khan AA, Khan S, et al. Molecular characteriza- tion of tetracycline-resistant genes and integrons from avirulent strains of Escherichia coli isolated from catfish[J]. Foodborne Pathoq Dis, 2009,6(5) : 553-559.

二级参考文献28

共引文献30

同被引文献135

  • 1肖观清,孔耀中,李导,陈斌鸿,叶佩仪,邵咏红,陈统清.尿路感染病原菌的分布及药物敏感分析[J].现代预防医学,2012,39(22):5928-5930. 被引量:5
  • 2邓小燕,魏衍超,潘昆贻.聚团肠杆菌的分离及药敏谱分析[J].热带医学杂志,2004,4(5):592-593. 被引量:3
  • 3赖雁平,张菊英,葛庚芝,李慎果,毕铃,司进.老年人聚团肠杆菌所致下呼吸道感染52例临床及耐药性分析[J].中华老年医学杂志,2005,24(12):904-905. 被引量:4
  • 4李向阳,邵卫华,刁恩杰,张洪林.温度、pH、药物对大肠杆菌抑制作用的量热法研究[J].食品科学,2007,28(6):252-255. 被引量:20
  • 5胡必杰,宗志勇,顾克菊.多重耐药菌感染控制最佳实践[M].上海:上海科学技术出版社,2012:108.
  • 6吴美凤,曾妃.多药耐药菌信息一览表在科室院感管理中的应用[J].中国实用护理杂志,2012,28(2):233.
  • 7Shinagawa N,Hasegawa M,Hirata K,et al.Bacteria isolatedfrom surgical infections and its susceptibilities to antimicrobialagents-special references to bacteria isolated between April2008and March 2009[J].Jpn J Antibiot,2010,63(2):105-170.
  • 8Kim H,Suzuki H,MatsuokaM,et al.Molecular mechanismof the acquisition of new-quinolone resistance in mycobacte-rium ieprae and mtuberculosis and rapid differentiation meth-ods for resistant bacilli[J].Nihon Hansenbyo Gakkai Zasshi,2011,80(1):17-27.
  • 9Clinical and Laboratory Standards Institute.Performancestandards for Antimicrobial susceptibility testing[S].M100-S17.CLSI,2007.
  • 10唐平,张勇昌,陈惠琴.住院患者双重及多药耐药菌感染的调查[J].中华医院感染学杂志,2009,8(6):418-419.

引证文献22

二级引证文献133

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部